Drug profile · INN
levomethadyl acetate hydrochloride
ORLAAM
levomethadyl acetate hydrochloride (ORLAAM) is a mu opioid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — levomethadyl acetate hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
levomethadyl acetate hydrochloride (ORLAAM) is a mu opioid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is levomethadyl acetate hydrochloride?
levomethadyl acetate hydrochloride (ORLAAM) is a mu opioid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for levomethadyl acetate hydrochloride?
ORLAAM is a marketed brand name for levomethadyl acetate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levomethadyl acetate hydrochloride?
levomethadyl acetate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.